09:51 EDT RAPT Therapeutics (RAPT) trading halted, volatility trading pause
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RAPT:
- Rapt Therapeutics, Jeyou announce data from Phase 2 trial of RPT904
- Rapt Therapeutics initiated with an Overweight at Barclays
- RAPT Therapeutics: Anticipated Catalysts and Growth Potential Drive Buy Rating
- Rapt Therapeutics price target raised to $41 from $24 at Clear Street
- Rapt Therapeutics: FDA clears IND application for Phase 2b trial of RPT904